Publication: A Multi-Center Study on the Efficacy of Eltrombopag in Management of Refractory Chronic Immune Thrombocytopenia: A Real-Life Experience
Loading...
Program
relationships.isAuthorOf
Author
Cekdemir, Demet
Guvenc, Serkan
Ozdemirkiran, Fusun
Eser, Ali
Topts, Tayfur
ÖZKOCAMAN, VİLDAN
ŞAHİN, HANDAN HAYDAROĞLU
ERMİŞ TURAK, Esra
Comert, Melda
Advisor
Language
Type
Publisher
Journal Title
Journal ISSN
Volume Title
Abstract
Objective: The aim of the present study was to evaluate the efficacy and safety of eltrombopag, an oral thrombopoietin receptor agonist, in patients with chronic immune thrombocytopenia (ITP).
Description
Source
Keywords
Keywords
Citation
Cekdemir D., Guvenc S., Ozdemirkiran F., Eser A., Topts T., ÖZKOCAMAN V., ŞAHİN H. H. , ERMİŞ TURAK E., Esen R., Comert M., et al., -A Multi-Center Study on the Efficacy of Eltrombopag in Management of Refractory Chronic Immune Thrombocytopenia: A Real-Life Experience-, TURKISH JOURNAL OF HEMATOLOGY, cilt.36, ss.230-237, 2019